Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10

Original Research

Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma

       
Total article views   HTML views PDF downloads Totals
2,802 Dovepress* 2,643+ 57 2,700
PubMed Central* 159 55 214
Totals 2,802 112 2,914
*Since 2 March 2023

View citations on PubMed Central and Google Scholar